Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04427202 · ClinicalTrials.gov registry record · NA
Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 306
- Enrollment target
NCT04427202 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 306 participants.
The verdict
NCT04427202, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
Study Summary
This study will evaluate the referral to harm reduction services (HRS) including syringe services, naloxone overdose prevention, substance use treatment referral, HIV, HCV, and STD testing and referral and linkage to care through capacity building of existing programs through client services data.
Interventions
- BEHAVIORAL Referral to harm reduction services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2023-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04427202
The ClinicalTrials.gov registry entry for NCT04427202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Referral to harm reduction services is the first listed.
NCT04427202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04427202 about?
NCT04427202 is a clinical study titled "Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)". This study will evaluate the referral to harm reduction services (HRS) including syringe services, naloxone overdose prevention, substance use treatment referral, HIV, HCV, and STD testing and referral and linkage to care through capacity building of existing programs through client services data.
What is the current status of trial NCT04427202?
This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2020-08-14. Estimated completion is 2023-08-16.
What interventions are being tested in trial NCT04427202?
The interventions under investigation include: Referral to harm reduction services (BEHAVIORAL).
Who is sponsoring clinical trial NCT04427202?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.